Cronos Group Inc (NASDAQ: CRON) on Tuesday, plunged -0.49% from the previous trading day, before settling in for the closing price of $2.04. Within the past 52 weeks, CRON’s price has moved between $1.85 and $3.14.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 53.82% annually for the last half of the decade. The company achieved an average annual earnings per share of 55.56%. With a float of $200.32 million, this company’s outstanding shares have now reached $381.30 million.
In an organization with 356 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 20.94%, operating margin of -32.38%, and the pretax margin is -45.22%.
Cronos Group Inc (CRON) Insider and Institutional Ownership
Observing investor behavior towards Drug Manufacturers – Specialty & Generic industry stocks is more important than anything else. The insider ownership of Cronos Group Inc is 47.60%, while institutional ownership is 12.06%.
Cronos Group Inc (CRON) Latest Financial update
As on 9/30/2024, Multinational firm has announced its last quarter scores, in which it reported -0.16 earnings per share (EPS) for the period falling under the consensus outlook (set at -0) by -0.16. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.01 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 55.56% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 45.80% during the next five years compared to -9.06% drop over the previous five years of trading.
Cronos Group Inc (NASDAQ: CRON) Trading Performance Indicators
Cronos Group Inc (CRON) is currently performing well based on its current performance indicators. A quick ratio of 23.05 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 9.73. Likewise, its price to free cash flow for the trailing twelve months is 58.54.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.12, a number that is poised to hit 0.00 in the next quarter and is forecasted to reach 0.03 in one year’s time.
Technical Analysis of Cronos Group Inc (CRON)
Let’s dig in a bit further. During the last 5-days, its volume was 1.25 million. That was inferior than the volume of 1.92 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 27.13%. Additionally, its Average True Range was 0.11.
During the past 100 days, Cronos Group Inc’s (CRON) raw stochastic average was set at 19.05%, which indicates a significant decrease from 27.91% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 76.83% in the past 14 days, which was higher than the 48.12% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.16, while its 200-day Moving Average is $2.34. However, in the short run, Cronos Group Inc’s stock first resistance to watch stands at $2.05. Second resistance stands at $2.07. The third major resistance level sits at $2.10. If the price goes on to break the first support level at $2.01, it is likely to go to the next support level at $1.98. The third support level lies at $1.96 if the price breaches the second support level.
Cronos Group Inc (NASDAQ: CRON) Key Stats
Market capitalization of the company is 1.08 billion based on 382,295K outstanding shares. Right now, sales total 87,240 K and income totals -73,960 K. The company made 34,260 K in profit during its latest quarter, and 8,350 K in sales during its previous quarter.
